Twin Lakes Capital Management’s ResMed RMD Stock Holding History

Twin Lakes Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-200	Closed	-$45.7K	–	240
2024 Q4	$45.7K	Hold	200	–	–	0.03%	145
2024 Q3	$48.8K	Hold	200	–	–	0.03%	144
2024 Q2	$38.3K	Hold	200	–	–	0.03%	151
2024 Q1	$39.6K	Hold	200	–	–	0.03%	153
2023 Q4	$34.4K	Hold	200	–	–	0.02%	154
2023 Q3	$29.6K	Hold	200	–	–	0.02%	158
2023 Q2	$43.7K	Hold	200	–	–	0.03%	140
2023 Q1	$43.8K	Hold	200	–	–	0.03%	141
2022 Q4	$41.6K	Hold	200	–	–	0.03%	144
2022 Q3	$44K	Buy	+200	New	+$45.5K	0.04%	141
2022 Q2	–	Sell	-200	Closed	-$49K	–	255
2022 Q1	$49K	Hold	200	–	–	0.03%	158
2021 Q4	$52K	Hold	200	–	–	0.03%	158
2021 Q3	$53K	Hold	200	–	–	0.03%	150
2021 Q2	$49K	Hold	200	–	–	0.03%	137
2021 Q1	$39K	Buy	+200	New	+$40.1K	0.02%	139

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Twin Lakes Capital Management's RMD Position: Q1 2025 in Review

Twin Lakes Capital Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 200 shares — an estimated $45.7K sold.

Twin Lakes Capital Management first reported a position in RMD in Q1 2021 and held it in 15 quarters. The position peaked at $53K in Q3 2021. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Twin Lakes Capital Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Twin Lakes Capital Management sold 200 ResMed shares in Q1 2025, an estimated $45.7K.
Twin Lakes Capital Management first reported a position in ResMed in Q1 2021 and held it in 15 quarters.
Twin Lakes Capital Management's ResMed position peaked at $53K in Q3 2021.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Twin Lakes Capital Management's 13F filing for Q1 2025, filed 23 May 2025.